$ cat ./records/gates-foundation-grants-20-million-to-moderna-to-develop-mrna-bas-2016.txt
Gates Foundation Grants $20 Million to Moderna to Develop mRNA-Based HIV Prevention
[RECORD.TXT] · cat --full
The Bill & Melinda Gates Foundation awarded a grant of up to $20 million to Moderna Therapeutics — through its infectious-disease venture Valera — to advance an mRNA-based antibody combination aimed at preventing HIV infection. The grant funded a preclinical evaluation phase and, if successful, a first-in-human Phase 1 clinical study. The partnership included the possibility of follow-on funding bringing total potential support to $100 million across additional mRNA global health projects. Gates Foundation president of global health Trevor Mundel said Moderna's technology had 'considerable potential' for HIV prevention.
Source: https://www.genengnews.com/topics/omics/moderna-wins-initial-20m-grant-from-gates-foundation/
Free forever · No ads · Solo developer
If this was worth a read, help make the next entry possible.
Every entry in this archive was researched, verified, and written by one person — for free. No corporate funding. No ad revenue. Just a developer who believes verified history should be accessible to everyone. Your donation directly funds new entries.
Crypto accepted · No subscription required
← Previous
Gates Foundation Funds ILRI Tick-Distribution Mapping Across Sub-Saharan Africa to Guide Livestock Disease Interventions
Next →
Launches Breakthrough Energy Ventures with $1 Billion in Committed Capital
[CROSS_REFERENCES] · grep --category='Global Health'
Related Accomplishments
January 2026
Gates-backed World Mosquito Program reaches 16 million people protected from dengue via Wolbachia method
The World Mosquito Program — backed in part by the Gates Foundation — announced in January 2026 that its Wolbachia-infected mosquito releases had reached over 16.1 million people across multiple countries, including Colombia, Indonesia, Brazil, Sri Lanka, Fiji, Vanuatu, and Vietnam. Wolbachia-carrying Aedes aegypti mosquitoes — which block dengue, Zika, chikungunya, and yellow fever transmission — had established self-sustaining populations in treated cities without requiring ongoing releases. Gold-standard randomised trials in Indonesia showed a 77% reduction in dengue incidence. The program represented one of the largest and most cost-effective vector control deployments in history.
2025
Gates-Funded Monoclonal Antibody Shows Early Promise as a Single-Shot Malaria Shield
[ARCHIVE_FUNDING] · INDEPENDENT · NO ADS
One developer. >300 verified entries. Zero ads. Forever free.
No sponsors, no paywall, no algorithm. If this archive has been useful to you, reader support is what keeps it running.